Title:
APTAMER TO FGF9 AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2020/204151
Kind Code:
A1
Abstract:
The present invention provides an aptamer binding to FGF9, which contains a nucleotide sequence represented by formula (I): CAAGGHTGCCG (SEQ ID NO: 37) (I) (wherein H represents A, C or T), etc.
Inventors:
ADACHI TATSUO (JP)
Application Number:
PCT/JP2020/015263
Publication Date:
October 08, 2020
Filing Date:
April 03, 2020
Export Citation:
Assignee:
RIBOMIC INC (JP)
International Classes:
A61K48/00; A61K31/7088; A61K38/43; A61K47/54; A61K47/59; A61K49/00; A61K51/04; A61P43/00; C07H21/00; C12N15/115
Foreign References:
| JP2012532612A | 2012-12-20 |
Other References:
GOLD L. ET AL.: "Aptamer-based Multiplexed Proteomic Technology for Biomarker Discovery", PLOS ONE, vol. 5, no. 12, 7 December 2010 (2010-12-07), pages e15004, XP055040606, DOI: 10.1371/journal.pone.0015004
17 December 2018 (2018-12-17), Retrieved from the Internet [retrieved on 20200604]
ANALYST NET COMPANY REPORT, 26 November 2019 (2019-11-26), Retrieved from the Internet [retrieved on 20200604]
MALEKZADEH A. ET AL.: "Plasma Proteome in Multiple Sclerosis Disease Progression", ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, vol. 6, no. 9, 31 July 2019 (2019-07-31), pages 1582 - 1594, XP055746800
HEGAB, A. E. ET AL.: "Effect of FGF/FGFR Pathway Blocking on Lung Adenocarcinoma and Its Cancer-Associated Fibroblasts", THE JOURNAL OF PATHOLOGY, vol. 249, no. 2, 24 June 2019 (2019-06-24), pages 193 - 205, XP055746801
17 December 2018 (2018-12-17), Retrieved from the Internet
ANALYST NET COMPANY REPORT, 26 November 2019 (2019-11-26), Retrieved from the Internet
MALEKZADEH A. ET AL.: "Plasma Proteome in Multiple Sclerosis Disease Progression", ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, vol. 6, no. 9, 31 July 2019 (2019-07-31), pages 1582 - 1594, XP055746800
HEGAB, A. E. ET AL.: "Effect of FGF/FGFR Pathway Blocking on Lung Adenocarcinoma and Its Cancer-Associated Fibroblasts", THE JOURNAL OF PATHOLOGY, vol. 249, no. 2, 24 June 2019 (2019-06-24), pages 193 - 205, XP055746801
Attorney, Agent or Firm:
TAKASHIMA, Hajime (JP)
Download PDF: